We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Applications of artificial intelligence in biliary tract cancers

    Biliary tract cancers are malignant neoplasms arising from bile duct epithelial cells. They include cholangiocarcinomas and gallbladder cancer....

    Pankaj Gupta, Soumen Basu, Chetan Arora in Indian Journal of Gastroenterology
    Article 01 March 2024
  2. Durvalumab: A Review in Advanced Biliary Tract Cancer

    Durvalumab (Imfinzi ® ), a therapeutic human monoclonal antibody which binds to and blocks the activity of the immunosuppressive programmed...

    Simon Fung, Yahiya Y. Syed in Targeted Oncology
    Article Open access 09 November 2023
  3. Safety of skip** the tract dilation step for EUS-guided biliary drainage in patients with unresectable malignant biliary obstruction (with video)

    Background

    Thin delivery system stents can be inserted directly without the need for a tract dilation step and are expected to reduce bile leakage...

    Masahiro Itonaga, Reiko Ashida, ... Masayuki Kitano in Surgical Endoscopy
    Article 15 March 2024
  4. Usefulness of contrast-enhanced ultrasonography for biliary tract disease

    Conventional ultrasonography (US) for biliary tract disease shows high time and spatial resolution. In addition, it is simple and minimally invasive,...

    Hiroshi Matsubara, Hirotaka Suzuki, ... Nobuyuki Kiura in Journal of Medical Ultrasonics
    Article 31 July 2023
  5. Skeletal muscle status and survival among patients with advanced biliary tract cancer

    Background

    Studies have demonstrated a prognostic role of sarcopenia ( i.e. , loss of skeletal muscle volume and functionality) in patients with...

    Shinya Takaoka, Tsuyoshi Hamada, ... Mitsuhiro Fujishiro in International Journal of Clinical Oncology
    Article Open access 06 February 2024
  6. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer

    Background

    Sarcopenia is a poor prognostic factor in cancer patients. In recent years, there have been reports that serum creatinine and cystatin C...

    Ryosuke Fukushima, Norifumi Harimoto, ... Ken Shirabe in International Journal of Clinical Oncology
    Article 29 April 2024
  7. Immunotherapy in Biliary Tract Cancers: Where Are We?

    Purpose of Review

    Biliary tract cancers (BTCs) are a heterogenous group of cancers arising from the biliary tract. The hallmark of these cancers is...

    Aparna Kalyan, Harshit Khosla, Richard D. Kim in Current Oncology Reports
    Article 04 October 2022
  8. Features of biliary tract diseases in ketamine abusers: a systematic review of case reports

    Background and aims

    Anesthesiologists prefer ketamine for certain surgeries due to its effectiveness as a non-competitive inhibitor of the...

    Alireza Teymouri, Hadis Nasoori, ... Aref Nasiri in Journal of Medical Case Reports
    Article Open access 03 March 2024
  9. Analysis of the efficacy and factors influencing survival of adjuvant radiotherapy for stage II-III biliary tract carcinoma

    Background

    To determine the efficacy of adjuvant radiotherapy for stage II–III biliary tract carcinoma.

    Methods

    We retrospectively analyzed the data...

    Yan-Ling Guo, Jia-**ng Guo, ... Ying-Na Bao in World Journal of Surgical Oncology
    Article Open access 26 October 2023
  10. Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation

    Background

    Excess body weight may modulate the progression of various cancer types. The prognostic relevance of body mass index (BMI) has not been...

    Shinya Takaoka, Tsuyoshi Hamada, ... Mitsuhiro Fujishiro in Journal of Gastroenterology
    Article 19 June 2024
  11. SIUMB recommendations on the use of ultrasound in neoplastic lesions of the gallbladder and extrahepatic biliary tract

    Extrahepatic biliary tract and gallbladder neoplastic lesions are relatively rare and hence are often underrepresented in the general clinical...

    Ilario de Sio, Mirko D’Onofrio, ... Fabia Attili in Journal of Ultrasound
    Article Open access 05 May 2023
  12. Frequency of infiltrating regulatory T-cells in the portal tract of biliary atresia

    Purpose

    Immunological abnormalities have been hypothesized as a pathogenesis of biliary atresia (BA). We previously investigated the frequency and...

    Satoru Oita, Takeshi Saito, ... Tomoro Hishiki in Pediatric Surgery International
    Article 01 September 2023
  13. CAR-T Cell Therapy in Pancreatic and Biliary Tract Cancers: An Updated Review of Clinical Trials

    Background

    Pancreatic and biliary tract cancers are digestive system tumors with dismal prognosis and limited treatment options. The effectiveness of...

    Konstantinos Drougkas, Konstantinos Karampinos, ... Elias Kotteas in Journal of Gastrointestinal Cancer
    Article 02 May 2024
  14. A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer

    Background

    Biliary tract cancers are rare aggressive malignancies typically diagnosed when the disease is metastatic or unresectable, precluding...

    Vivian Peirce, Michael Paskow, ... Sukhvinder Johal in Targeted Oncology
    Article Open access 26 September 2023
  15. Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer

    Purpose

    To elucidate the clinical significance of peritoneal washing cytology (PWC) in patients with resectable biliary tract cancer (BTC).

    ...
    Tatsuaki Sumiyoshi, Kenichiro Uemura, ... Shinya Takahashi in Langenbeck's Archives of Surgery
    Article Open access 22 January 2024
  16. Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers

    Primary cancers of the liver and biliary tract are rare and aggressive tumors that often present with locally advanced or metastatic disease. For...

    Samantha M. Ruff, Jordan M. Cloyd, Timothy M. Pawlik in Annals of Surgical Oncology
    Article 11 September 2023
  17. Transmission of oral microbiota to the biliary tract during endoscopic retrograde cholangiography

    Background

    Endoscopic retrograde cholangiography (ERC) possesses a translocation risk of microbes to the biliary system. We studied bile contamination...

    Maria Effenberger, Ramona Al-Zoairy, ... Heinz Zoller in BMC Gastroenterology
    Article Open access 03 April 2023
  18. Risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography in patients with biliary tract diseases

    Background

    To investigate the risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary tract...

    **-yuan Chi, Lin-ya Ma, ... Yue-feng Ma in BMC Surgery
    Article Open access 23 March 2023
  19. Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer

    Purpose

    This study aimed to elucidate the difficulty of adjuvant chemotherapy administration in patients with biliary tract carcinoma (BTC).

    ...
    Tatsuaki Sumiyoshi, Kenichiro Uemura, ... Shinya Takahashi in Langenbeck's Archives of Surgery
    Article 24 November 2023
  20. Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinoma

    Immune-related liver injuries are closely associated with the liver’s fundamental state. Patients with advanced biliary tract carcinoma (BTC) have...

    Zhao Gao, Shikai Wu, ... Xuan ** in Investigational New Drugs
    Article 17 August 2023
Did you find what you were looking for? Share feedback.